TY - JOUR
T1 - PAX6 maintains β cell identity by repressing genes of alternative islet cell types
AU - Swisa, Avital
AU - Avrahami, Dana
AU - Eden, Noa
AU - Zhang, Jia
AU - Feleke, Eseye
AU - Dahan, Tehila
AU - Cohen-Tayar, Yamit
AU - Stolovich-Rain, Miri
AU - Kaestner, Klaus H.
AU - Glaser, Benjamin
AU - Ashery-Padan, Ruth
AU - Dor, Yuval
N1 - Funding Information:
This work was supported by grants from the Juvenile Diabetes Research Foundation (JDRF); the Beta Cell Biology Consortium and the Human Islet Research Network of the NIH (DK104216); the Helmsley Charitable Trust; the European Research Commission (ERC consolidator grant); the Britain Israel Research and Academic Exchange Partnership (BIRAX); the Diabetes Onderzoek Nederland (DON) Foundation; and the Israel Science Foundation and I-CORE Program of The Israel Science Foundation (ISF) (41.11, to YD). Research was performed with the support of the Network for Pancreatic Organ Donors with Diabetes (nPOD), a collaborative type 1 diabetes research project sponsored by the JDRF. The Organ Procurement Organizations (OPOs) partnering with nPOD to provide research resources are listed on the nPOD/JDRF partners website (http://www.jdrfnpod.org/for-partners/npod-partners/). This work was supported in part by a grant from USAID's American Schools and Hospitals Abroad Program for the upgrading of the Hebrew University Medical School's Flow Cytometry Laboratory. RA-P was supported by the United States-Israel Binational Science Foundation (BSF; grant 2013016) and the ISF (grant 228/14). AS received fellowships from the Adams Foundation and the Ariane de Rothschild Women Doctoral Program
PY - 2017/1/3
Y1 - 2017/1/3
N2 - Type 2 diabetes is thought to involve a compromised β cell differentiation state, but the mechanisms underlying this dysfunction remain unclear. Here, we report a key role for the TF PAX6 in the maintenance of adult β cell identity and function. PAX6 was downregulated in β cells of diabetic db/db mice and in WT mice treated with an insulin receptor antagonist, revealing metabolic control of expression. Deletion of Pax6 in β cells of adult mice led to lethal hyperglycemia and ketosis that were attributed to loss of β cell function and expansion of α cells. Lineage-tracing, transcriptome, and chromatin analyses showed that PAX6 is a direct activator of β cell genes, thus maintaining mature β cell function and identity. In parallel, we found that PAX6 binds promoters and enhancers to repress alternative islet cell genes including ghrelin, glucagon, and somatostatin. Chromatin analysis and shRNA-mediated gene suppression experiments indicated a similar function of PAX6 in human β cells. We conclude that reduced expression of PAX6 in metabolically stressed β cells may contribute to β cell failure and α cell dysfunction in diabetes.
AB - Type 2 diabetes is thought to involve a compromised β cell differentiation state, but the mechanisms underlying this dysfunction remain unclear. Here, we report a key role for the TF PAX6 in the maintenance of adult β cell identity and function. PAX6 was downregulated in β cells of diabetic db/db mice and in WT mice treated with an insulin receptor antagonist, revealing metabolic control of expression. Deletion of Pax6 in β cells of adult mice led to lethal hyperglycemia and ketosis that were attributed to loss of β cell function and expansion of α cells. Lineage-tracing, transcriptome, and chromatin analyses showed that PAX6 is a direct activator of β cell genes, thus maintaining mature β cell function and identity. In parallel, we found that PAX6 binds promoters and enhancers to repress alternative islet cell genes including ghrelin, glucagon, and somatostatin. Chromatin analysis and shRNA-mediated gene suppression experiments indicated a similar function of PAX6 in human β cells. We conclude that reduced expression of PAX6 in metabolically stressed β cells may contribute to β cell failure and α cell dysfunction in diabetes.
UR - http://www.scopus.com/inward/record.url?scp=85008395154&partnerID=8YFLogxK
U2 - 10.1172/JCI88015
DO - 10.1172/JCI88015
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 27941241
AN - SCOPUS:85008395154
SN - 0021-9738
VL - 127
SP - 230
EP - 243
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 1
ER -